Company intelligence / Profile preview

Lekar Pharma

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Lekar Pharma is a commercial-stage pharmaceutical company specializing in branded generics and formulations. Its pharmaceutical business undertaking was acquired by J.B. Chemicals & Pharmaceuticals in 2020. The company is well-known for its pain management and anti-infective products, including the major brand Dicloran.

Therapeutic areas: ImmunologyCardiovascularNeurologyInfectious DiseasesRheumatologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Spectrum Pharmaceuticals

Beyond the preview

Go deeper on Lekar Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lekar Pharma.

Explore the full profile